Delivery Order SPE2DB22D3011-SPE2DB25FP8RR

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,002.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a critical pharmaceutical product. The contract has an ultimate completion date of January 14, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, valued at $18,999.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a critical medical product, to support military healthcare programs. This is a firm-fixed-price delivery order contract with a period of performance through February 4, 2025. The contract was awarded without a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The contract has a firm fixed price of $3,816.98 and a period of performance through November 21, 2024. The award is a delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.17 firm fixed-price delivery order is for VIVITROL 380 MG VIAL-DILUENTS and has a completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialized medication. The contract has a ceiling value of $12,014.04 and a period of performance through January 24, 2025. The contract is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the government. The $2,742.93 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The firm-fixed-price delivery order, valued at $3,003.51, has a completion date of February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,905.60 Firm Fixed Price Delivery Order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialized medication. The contract has a period of performance through May 24, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,485.86 Firm Fixed Price Delivery Order contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, with an ultimate completion date of October 24, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $4,004.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medical product used in various healthcare applications. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This $999,999,999 IDC, which runs through November 2026, serves as a...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP8RR
    Delivery Order

This federal contract award, valued at $2,170.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026.

The contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, to support military healthcare programs globally. The contract has a firm fixed price and a performance period ending on January 16, 2025. The place of performance is Conshohocken, Pennsylvania. This contract award did not have a set-aside designation, indicating open competition.

Generated 4/17/25, 8:59 AM